Medpace GAAP EPS of $3.86 beats by $0.34, revenue of $659.9M beats by $18.92M
Source: SeekingAlpha
2025-10-22 16:20:16 ET
More on Medpace
- Medpace: Profit Margin, Growth, And Repurchase Program Will Trump Legislative Headwinds (Rating Upgrade)
- Medpace: Return Of The Mack, With Double-Digit Revenue Growth
- Medpace Q3 2025 Earnings Preview
- Jefferies rates IQVIA, Charles River as Buy, ICON as Hold
- Seeking Alpha’s Quant Rating on Medpace
Read the full article on Seeking Alpha
For further details see:
Medpace GAAP EPS of $3.86 beats by $0.34, revenue of $659.9M beats by $18.92M
Medpace Holdings Inc.
NASDAQ: MEDP
MEDP Trading
-0.75% G/L:
$450.99 Last:
111,208 Volume:
$450.52 Open:
MEDP Latest News
February 23, 2026 12:10:00 am
Ongoing Investigation: Medpace Holdings, Inc. (MEDP) May Have Misled Shareholders - Levi & Korsinsky Investigates
February 18, 2026 09:00:00 am
Medpace Holdings Under Investigation After Book-to-Bill Miss Exposes Cancellation Surge and Pipeline Fragility
February 16, 2026 01:50:00 pm
Why Big Stock Swings Like Medpace's 55% Jump Usually Have Clear Causes--Not Market Madness
MEDP Stock Data
$12,487,114,097
22,450,074
3.25%
359
N/A
Biotechnology & Life Sciences
Healthcare
US
Cincinnati
